OR AKIVA, Israel, June 21, 2011 /PRNewswire/ --
Deep Breeze, The leader
in Vibration Response Imaging (VRI) technology, will showcase its
new lung imaging systems embedded with the O-Plan application, at
the WCLC (The
14th World Conference on Lung Cancer) annual meeting in Amsterdam,
The Netherlands, which will take place on July 3-7, 2011 at the RAI
Conference Center (booth 2312).
Deep Breeze's VRI systems are now integrated with advanced
interactive software tailored specifically for thoracic surgeons;
this software enables the physician to automatically calculate the
predicted post-operative (PPO) lung function for high and low risk
lung cancer patients prior to resection surgery.
The O-Plan application, with radiation-free VRIxp recordings,
can be implemented as an alternative to nuclear perfusion scans
that are performed prior to lung resections. The VRI O-Plan tool
enables regional lung imaging quantification, which has been shown
to be reliably correlative to the regional distribution of the
perfusion. Additionally, following observations and trials of
hundreds of patients, the VRI O-Plan tool has shown highly accurate
post-surgery predictions compared to the VQ Perfusion Scan results
and most importantly, the O-Plan has also shown highly accurate
post-surgery pulmonary function prediction in comparison to actual
lung function parameters (FEV1, DLCO) in patients, a few weeks
after lung resection surgery.
"Our FDA-approved VRIxp lung imaging system offers an easy
and radiation-free method to automate a calculation that
is typically performed manually by physicians, when considering
physiologic data prior to resection surgery," said Dr. Miki Nagler,
CEO at Deep Breeze. "The procedure can be performed in the
pulmonary function testing lab or directly in the surgeon's or
"Predictions based on lung function testing and quantitative
breath sound measurements demonstrated high correlations with
quantitative perfusion estimations and corroborate previously
published results," said DR.
Frank C. Detterbeck, professor of Thoracic
Surgery at the Yale University Medical Center. "Given its
simplicity of operation, lack of radiation and the non-invasive
nature of VRIxp testing, it could be a good alternative to
quantitative perfusion scans in preoperative lung resection
Clinical use of the VRI systems with the O-Plan application in
Germany, Canada, Spain, Turkey, Russia, the Czech Republic and
China, reveal that this technique is suitable for wide use in
predicting post-operative lung function in patients with lung
About Deep Breeze
Founded in 2001, Deep Breeze is a privately-held medical device
company that provides advanced pulmonary imaging with its
proprietary patented technology, Vibration Response Imaging (VRI).
The Company has conducted clinical studies globally to evaluate VRI
efficacy in fields such as: general pulmonology, COPD, CHF, asthma,
interventional pulmonology, lung cancer, lung transplant and
critical care patient management.
For additional information, please visit our website: http://www.deepbreeze.com.
Hagai ben Asher
Senior Sales Director
SOURCE Deep Breeze